GlobalData on MSN4mon
FDA grants approval to commence trial of R3 Vascular’s scaffoldthis scaffold is intended to treat below-the-knee (BTK) peripheral arterial disease (PAD). When combined with R3 Vascular's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback